Adiponectin: Serum-saliva associations and relations with oral and systemic markers of inflammation by Riis, Jenna L et al.
1 
 
Adiponectin: Serum-Saliva Associations and Relations with Oral and Systemic Markers 
of Inflammation  
Jenna L. Riis,1,2 Crystal I. Bryce,2,3 Thao Ha,2,4 Tracey Hand,7 John L. Stebbins,8 Marla 
Matin,8 Katrin M. Jaedicke9 & Douglas A. Granger1,2,5,6,8,10  
1Department of Population, Family, and Reproductive Health,  
Johns Hopkins University Bloomberg School of Public Health, MD, USA  
2Institute for Interdisciplinary Salivary Bioscience Research, University of California, 
Irvine CA USA  
3Sanford School of Social and Family Dynamics, 4Department of Psychology 
Arizona State University, Tempe, AZ, USA  
5Department of Acute and Chronic Care,  
Johns Hopkins University School of Nursing, MD, USA  
6Department of Pediatrics and 7Institute for Genomic Medicine,  
Johns Hopkins University School of Medicine, MD, USA 
 
8Salimetrics Research and Technology Center, Carlsbad, CA, USA 
 
9School of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK 
 
10Salivary Bioscience Laboratory and Department of Psychology, University of 
Nebraska, Lincoln, USA  
Correspondence: Jenna L. Riis (jriis1@jhu.edu) or Douglas A. Granger 
(IISBR@uci.edu), Institute for Interdisciplinary Salivary Bioscience Research, University 
of California at Irvine, 4201 Social and Behavioral Sciences Gateway, Irvine CA 92697-
7085.    
Acknowledgement: We thank Mary Twomley and Walter Worley for coordination of 
biospecimen collection; John Peterson and Steven W. Granger at Salimetrics for technical 
advice; and Salimetrics (Carlsbad, CA) for contributing some reagents.  
2 
 
 
Disclosure statement: In the interest of full disclosure, DAG is founder and chief 
scientific and strategy advisor at Salimetrics LLC and Salivabio LLC and these 
relationships are managed by the policies of the committees on conflict of interest at the 
Johns Hopkins University School of Medicine and the University of California at Irvine.     
3 
 
Abstract  
This study addresses gaps in our understanding about the validity and utility of 
using salivary adiponectin to index serum adiponectin levels. Matched blood and saliva 
samples were collected on a single occasion from healthy adults (n= 99; age 18-36 years, 
53% male).  Serum and saliva was assayed for adiponectin and inflammatory cytokines 
(IL-1β, IL-6, IL-8, TNFα), and saliva was also assayed for markers of blood 
contamination (transferrin), total protein (salivary flow rate) and matrix 
metalloproteinase-8 (MMP-8).  We examined the extent to which salivary adiponectin 
was associated with serum adiponectin, and the influence of potential confounders on the 
serum-saliva correlation, including age, sex, body mass index, and markers of 
inflammation, oral health, salivary blood contamination, and flow rate.  Findings revealed 
a modest serum-saliva association for adiponectin, and strong positive associations 
between salivary adiponectin and salivary levels of inflammatory cytokines, MMP-8, 
transferrin, and total protein.  By contrast, salivary adiponectin was not related to serum 
levels of inflammatory activity. The magnitude of the serum-saliva association was 
strengthened when controlling for total protein in saliva, blood leakage into oral fluid, 
salivary inflammatory cytokines, and MMP-8. The pattern of findings extends our 
understanding of salivary adiponectin and its potential use as an index of circulating 
adiponectin levels.  
 
Keywords: saliva; serum; adiponectin; cytokines; inflammation; oral health 
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Introduction 
Adipose tissue secretes bioactive proteins, known as adipocytokines, into 
circulation. Among the important members of the adipocytokine family is adiponectin 
(Scherer, Williams, Fogliano, Baldini, & Lodish, 1995).  Adiponectin modulates several 
metabolic processes including glucose and lipid metabolism in insulin-sensitive tissues.  
Studies suggest that adiponectin has anti-atherogenic and anti-inflammatory properties, 
and adiponectin levels are associated with a range of cardiovascular and metabolic 
diseases (Fasshauer & Bluher, 2015; Li & Wu, 2012; Robinson, Prins, & Venkatesh, 
2011). Adiponectin levels are lower in patients with essential hypertension and type-2 
diabetes, and adiponectin is associated with insulin resistance, triglycerides and HDL 
cholesterol levels (Lihn, Pedersen, & Richelsen, 2005; Nigro et al., 2014; Vaiopoulos, 
Marinou, Christodoulides, & Koutsilieris, 2012).  Given its role in metabolic diseases, 
adiponectin may be important in tracking and diagnosing some of the most rapidly 
growing and costly diseases in the United States (e.g., prediabetes/insulin resistance, 
metabolic syndrome, and vascular disease; Ebrahimi-Mamaeghani, Mohammadi, 
Arefhosseini, Fallah, & Bazi, 2015; Lopez-Jaramillo et al., 2014; Stojanović, Ilić, Ilić, 
Petrović, & Djukić, 2015). 
 Adiponectin is also produced locally in the oral cavity by salivary glands 
(Katsiougiannis, Kapsogeorgou, Manoussakis, & Skopouli, 2006).  As such, adiponectin 
plays a role in oral inflammation and the oral immune response.  Salivary adiponectin has 
potent beneficial functions on the maintenance and homeostasis of periodontal health 
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(Iwayama et al., 2012; Kraus et al., 2012). The relationship between protein levels in oral 
fluids and plasma makes oral fluid an attractive biospecimen that could be used as an 
alternative to blood in tests measuring adiponectin.  Many studies suggest that the 
measurement of adiponectin in saliva by immunoassay is feasible, minimally-invasive, 
and may be an acceptable alternative to plasma sampling (Desai & Mathews, 2014; Nigro 
et al., 2015).  However, more research on the relationship between adiponectin levels in 
serum and saliva is needed as some studies report low levels of correspondence in serum 
and saliva (Mamali et al., 2012; Thanakun, Watanabe, Thaweboon, & Izumi, 2013).  To 
the best of our knowledge, studies also have yet to account for a host of potential 
confounding factors when assessing the serum-saliva relations of adiponectin (for one 
exception, see Akuailou, Vijayagopal, Imrhan, & Prasad, 2013).   
One of the most important factors potentially confounding the adiponectin serum-
saliva correlation is inflammation in the oral mucosal immune compartment, as the extent 
of adiponectin activity in saliva might be strongly associated with oral health, rather than 
metabolic processes. In addition to oral inflammation, poor oral health or injury (e.g., 
open wounds, abrasion) may also cause blood leakage into saliva which can confound 
salivary determinations of adiponectin. Furthermore, variation in local oral mucosal 
immune responses is largely confined to that particular compartment and relatively 
independent of the more general systemic level of immune activation (e.g., Kindt, 
Osborne, & Goldsby, 2006).  Correspondingly, in contrast to the strong serum-saliva 
associations for many endocrine markers, the serum-saliva correlations for immune 
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markers has been shown to be small to modest (e.g., Nishanian, Aziz, Chung, Detels, & 
Fahey, 1998; Riis et al., 2013).  Thus, characteristics of oral health and inflammation may 
significantly compromise the possibility of using salivary measures of immune-sensitive 
analytes, such as adiponectin, as an alternative to blood measures.    
Present Study 
We investigated the utility of salivary adiponectin as an index of circulating 
adiponectin and relations between adiponectin and oral and systemic inflammatory 
activity.  More specifically, using adiponectin assayed from matched serum and saliva 
samples from healthy young adults, we: 1) compare adiponectin levels in serum and 
saliva, (2) examine the extent to which salivary adiponectin is associated with oral health 
using both self-reported measures of oral hygiene practices and a known biomarker of 
oral health (matrix metalloproteinase-8 (MMP-8)); 3) examine the associations between 
adiponectin and inflammatory markers both within and across biospecimens; 4) examine 
the associations between salivary adiponectin levels and blood contamination and 
salivary total protein; 5) explore relations between adiponectin levels in serum and saliva 
and age, sex, and body mass index; and 6) examine the serum-saliva correlation for 
adiponectin. 
To further interrogate the relation between serum and salivary adiponectin, we 
also examine serum-saliva correlations controlling for salivary indictors of leakage of 
serum into the oral mucosal compartment and salivary total protein.  Furthermore, based 
on previous studies (Riis et al., 2013), we hypothesize that salivary adiponectin is 
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positively associated with measures of oral inflammatory activity and oral health, and, 
therefore, we also examine the serum-saliva correlation for adiponectin when controlling 
for measures of oral inflammatory activity and oral health.  We hypothesize that the 
serum-saliva correlation will become stronger when we control for indicators of oral 
inflammation and oral health.  
     Methods 
Participants 
  The sample consisted of 99 adults ranging between 18 and 36 years old. 
Participants were mostly white (n= 45; 45%), 18% were Black/African American, 5% 
were South East Indian, 5% were Native Hawaiian, and 27% were of other or mixed 
race/ethnicities. To be eligible, participants had to be 18 to 36 years old, not currently 
under a physician’s care for any acute or chronic medical conditions, not taking 
prescription or over the counter medication (not including oral contraceptives), without 
open wounds and sores in their mouths, and have had no recent dental surgery.  
Procedures  
Data were collected in 2012-2013.  All participants provided written informed 
consent and the Johns Hopkins University Bloomberg School of Public Health 
Institutional Review Board approved all study procedures. During a single 45-minute 
assessment, participants completed a demographic survey and provided blood and saliva 
samples. Participants were compensated $50 for their time.   
Blood and Saliva Collection 
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Blood was drawn by venipuncture into 2 mL lavender/EDTA tubes. Additionally, 
a SST Tiger serum separator tube (BD, Becton-Dickenson) of blood was drawn for serum 
isolation. EDTA/whole blood was mixed well by inversion and spun at 900 xg for 15 
minutes.  The top plasma layer was transferred into 4x1 mL aliquots which were snap 
frozen and stored at -80 ̊C.  Serum was mixed well by inversion and allowed to clot at 
room temperature for 30 minutes but not longer than two hours.  Serum was aliquoted 
into 4x1 mL aliquots and subsequently stored at -80 ̊C until assayed.   
Following Granger and colleagues (Granger et al., 2007), whole unstimulated 
saliva was collected by passive drool and aliquoted into 2 mL cryogenic vials. Saliva 
samples were snap frozen and stored at -80 ̊C until assayed.   
Measures 
 Health and Demographic Information. Participants reported their age, sex, 
race/ethnicity, height and weight. Body mass index (BMI) was calculated for each 
participant using the Centers for Disease Control and Prevention’s BMI formula (CDC, 
2015). Participants also reported on their current oral hygiene practices. Specifically, 
participants indicated the number of times they flossed per week, the number of times 
they brushed their teeth per day, and whether or not their saliva had a red/pinkish color 
when they brushed their teeth (yes/no). 
 Determination of Salivary and Circulating Biomarkers 
Adiponectin.  Salivary adiponectin was measured using a multiplex 
electrochemiluminescence assay (Meso Scale Discovery, Gaithersburg, MD, USA). The 
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assay had a test volume of 10 µl test and a range of sensitivity from 0.00529 to 200 
ng/mL. The inter- and intra-assay coefficients of variation (CVs) were less than 5%. 
Serum adiponectin was measured using a commercial kit (EMD Millipore Corporation, 
cat# EZHADP-61K) with no modification to the manufacturer’s recommended protocol. 
The assay had a test volume of 10 µL (diluted 1:500) and a lower limit of detection 
(LLD) of 0.2 ng/µL.  The intra- and inter-assay CVs were 10.3% and 2.1%, respectively. 
Cytokines. Salivary and serum cytokines were used to index oral and systemic 
inflammatory activity.  Cytokines were measured using a 96-well format multiplex (9-
plex) electrochemiluminescence immunoassays manufactured by Meso Scale Discovery 
(MSD, Gaithersburg, MD). Each well of a 96-well plate was coated with capture-
antibodies specific to nine cytokines (granulocyte macrophage colony-stimulating factor 
(GM-CSF), interferon gamma (IFNγ), TNFα, interleukin (IL)-1β, IL-2, IL-6, IL-8, IL-10 
and IL-12p70). Detection antibodies were coupled to SULFOTAGTM labels that emit 
light when electrochemically stimulated via carbon-coated electrodes in the bottom each 
microwell. The assay was run following the manufacturer’s recommended protocol 
without modification and using standard diluent (MSD # R51BB). Cytokine 
concentrations were determined with MSD Discovery Workbench Software (v. 3.0.17) 
using curve fit models (4-PL with a weighting function option of 1/y2). GM-CSF, IL-2, 
IFNγ, IL-10 and IL-12p70 were not examined in the current analyses, because these 
analytes were either not available in serum (GM-CSF, IL-2) or had high rates of censored 
data in saliva (>20% of determinations below the LLD). Lower limits of detection were: 
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IL-1β (0.08 pg/mL), IL-6 (0.08 pg/mL), IL-8 (0.20 pg/mL), and TNFα (0.18 pg/mL). 
Intra-assay CVs for saliva were: IL-1β (2.4%), IL-6 (4.0%), IL-8 (2.0%), and TNFα 
(3.4%). Inter-assay CVs for saliva were: IL-1β (1.9%), IL-6 (3.8%), IL-8 (5.8%), and 
TNFα (7.1%). Intra-assay CVs for serum were: IL-1β (3.1%), IL-6 (2.3%), IL-8 (4.9%), 
and TNFα (4.8%). Inter-assay CVs serum were: IL-1β (3.9%), IL-6 (2.4%), IL-8 (6.1%), 
and TNFα (5.0%). 
Matrix Metalloproteinase-8. Salivary MMP-8 was assessed as a biomarker for 
oral health (Sorsa, Tjaderhane, & Salo, 2004). Levels were tested using a commercially 
available development kit (DuoSet ELISA, R&D Systems, cat# DY908) and following 
manufacturer’s guidelines. Samples were diluted 1:50 in Phosphate-buffered saline (PBS) 
containing 1% BSA Fraction5 (Akron Cat#11103090148) followed by a PBS/ 0.05% 
Tween® (Sigma-Aldrich 129K00412) wash. The test volume was 10 µL. The range of 
sensitivity for the assay was 62.5 to 4000 pg/mL. The inter- and intra-assay were 5.2% 
and 3.7%, respectively.   
Salivary Transferrin. Following Kivlighan and colleagues (Kivlighan et al., 
2004), saliva samples were assayed for blood contamination using a commercially 
available enzyme immunoassay kit for transferrin (Salimetrics, State College, PA). The 
test volume was 20 µl, and the range of sensitivity was 0.08 to 6.6 mg/dL. The inter- and 
intra-assay CVs were 4.7% and 2.9%, respectively.  
Salivary Total Protein. Salivary total protein was examined as an indirect 
indicator of salivary flow rate.  Total protein was determined using a commercial protein 
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assay kit (Pierce™ BCA Catalog # 23225, ThermoScientific) and following the 
manufacturer’s guidelines for the microplate procedure. The test volume was 25 µl and 
the range of sensitivity was 20 to 2000 μg/mL. Saliva samples were assayed neat 
(undiluted). After incubation, the 96-well plate was read in an ELx800 absorbance reader 
(BioTek) at 562 nm and analyzed in Gen5 software using a four-parameter logistical 
curve fit against an albumin standard (cat# 23209 PierceTM) prepared by serial dilution in 
PBS. 
Analytic Plan 
 The quality of the serum and salivary analyte data was first examined, including 
the level of censoring due to undetectable concentrations and the distribution of the data 
for each analyte. Determinations falling below the LLD were replaced as missing. All 
analyte data were positively skewed.  Data were Winsorized and log-transformed to 
improve the normality of the distributions. Winsorization was performed by analyte to 
bring all concentrations within four standard deviations of the mean. Raw data for all 
analytes were first examined, then Winsorized and log-transformed data were used in all 
subsequent statistical analyses. 
Levels of adiponectin in serum and saliva were compared using paired samples t-
tests. The association between salivary adiponectin and oral health was examined using 
both self-reported and biologic measures of oral hygiene practices and health.  First, 
Pearson correlations examined variation in salivary adiponectin by the number of times 
participants reported flossing per week.  A Kruskal-Wallis test examined differences in 
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salivary adiponectin by the frequency of brushing per day, and an independent samples t-
test examined whether salivary adiponectin levels were different for participants who 
reported red/pink tinted saliva when brushing and those that did not. The relation between 
salivary adiponectin and oral health was also examined using Pearson correlation with 
salivary adiponectin and salivary MMP-8.   
The association between adiponectin and inflammatory activity was examined 
within and across biospecimens using Pearson correlations and serum and salivary 
determinations of adiponectin, IL-1β, IL-6, IL-8, and TNFα.  Further, a principal 
components analysis (PCA) was conducted to assess the correlation structure of the 
inflammatory biomarkers in saliva, and to determine whether a composite score for 
salivary inflammatory activity could be constructed. A PCA of the four salivary 
inflammatory biomarkers (IL-1β, IL-6, IL-8, and TNFα) pointed to one underlying 
component explaining approximately 76% of the variance in inflammatory biomarker 
levels. The single factor PCA solution resulted in high component loadings for all four 
analytes ranging from 0.83-0.92.  A composite score for the oral inflammatory markers 
was derived from the PCA using the regression method. The associations between the 
composite oral inflammatory activity score and salivary and serum adiponectin was 
assessed using Pearson correlations.  
The influence of blood contamination and salivary flow rate on salivary 
adiponectin was examined using Pearson correlations between salivary adiponectin and 
salivary transferrin and total protein (separately).  The associations between both serum 
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and salivary adiponectin and participant age and BMI were assessed with bivariate 
correlations.  Independent samples t-tests were used to examine sex difference in serum 
and salivary adiponectin. 
The serum-saliva correlation for adiponectin was examined using Pearson 
correlation.  Partial Pearson correlations were conducted to examine the serum-saliva 
associations for adiponectin controlling for serum leakage into the oral mucosal 
compartment (transferrin), salivary flow rate (total protein), oral inflammatory activity 
(cytokines) and oral health (MMP-8). All analyses were conducted using SPSS 22. 
Results 
Participants 
 Participants were about half male (53% male) and the mean age was 23.76 years 
old (SD= 4.57).  Most participants were of a healthy weight, with 61% of participants 
falling in the “normal” range for BMI (mean BMI= 23.56, SD= 3.67, range= 15.78, 
36.96).   
 On self-reported measures of oral hygiene practices, participants flossed, on 
average, 2.07 times a week (SD= 2.29, range= 0-7 times a week), and brushed their teeth 
between one and three times a day (M= 1.98, SD= 0.36).  Twenty-seven percent of 
participants reported bleeding gums.    
Descriptive Statistics of all Analytes 
Table 1 displays descriptive statistics for all analytes using raw data (censored 
determinations were replaced with zero for descriptive purposes in this table).  Across all  
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analytes 0-2% of concentrations were Winsorized.    
Table 1. Descriptive Statistics of Raw Data for all Analytes in Saliva and Serum (N=99). 
 Number of undetectable samples Number of samples CV > 15% Mean SD Minimum Maximum 
Saliva       
Adiponectin (ng/mL) 0 0 9.87 10.75 .33 59.22 
MMP-8 (pg/mL) 0 6 63822.42 45251.89 957.16 203033.28 
IL-1β (pg/mL) 0 0 264.04 255.85 9.10 1591.18 
IL-6 (pg/mL) 0 0 10.09 16.72 .35 120.93 
IL-8 (pg/mL) 0 0 935.77 714.76 109.11 3374.14 
TNFα (pg/mL) 0 0 5.13 11.95 .16 110.67 
Total Protein (mg/mL) 0 0 700.76 364.09 148.50 1911.20 
Transferrin (mg/dL) 3 0 .72 .85  0.00 4.69  
Serum       
Adiponectin (µg/mL) 0 0 11.06 5.07 2.82 32.61 
IL-1β (pg/mL) 0 0 1.20 .77 .28 6.23 
IL-6 (pg/mL) 0 0 1.25 2.45 .17 18.90 
IL-8 (pg/mL) 0 0 15.43 33.29 2.26 246.20 
TNFα (pg/mL)  0 0 4.77 12.55 .93 111.72 
Note. Samples that were not detectable because they were below the assay lower limit of 
detection were set to 0 for the purpose of descriptive statistics only. CV=coefficients of 
variation; SD=Standard deviation; MMP-8= matrix metalloproteinase-8; IL-
1β=interleukin-1β; IL-6=interleukin-6; IL-8=interleukin-8; TNFα=tumor necrosis factor 
alpha. 
 
 
Comparison of Adiponectin in Serum and Saliva 
Levels of adiponectin in serum were higher than in saliva (Table 1; t(95)= 79.58, 
p < .01).   
Salivary Adiponectin and Oral Health 
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Salivary adiponectin was not significantly related to the frequency of flossing per 
week nor the frequency of daily brushing. There were also no significant differences in 
salivary adiponectin levels for individuals who reported bleeding gums compared to 
those who did not.  Salivary adiponectin was, however, significantly positively associated 
with salivary MMP-8 (Table 2).  
 
Table 2. Correlations Between Adiponectin and Other Analytes in Saliva and Serum  Salivary Adiponectin Serum Adiponectin  N Pearson’s r N Pearson’s r 
Salivary Analytes     
MMP-8 87 .65* 90 .04 
IL-1β 96 .62* 99 -.06 
IL-6 96 .74* 99 .13 
IL-8 96 .74* 99 .18 
TNFα 96 .56* 99 -.01 
Composite Oral Inflammatory 
Activity Score 
96 
.76* 84 .07 
Total Protein 96 .47* 99  
Transferrin 93 .79* 96   
Serum Analytes     
IL-1β 96 -.19 99 -.02 
IL-6 96 .06 99 .04 
IL-8 96 .06 99 .15 
TNFα 96 -.15 99 -.03 
* p<.01.  MMP-8= matrix metalloproteinase-8; IL-1β=interleukin-1β; IL-6=interleukin-6; 
IL-8=interleukin-8; TNFα=tumor necrosis factor alpha. 
 
Adiponectin and Inflammatory Activity 
Salivary adiponectin was positively associated with all salivary inflammatory 
cytokines and with the composite oral inflammatory activity score (Table 2; Figure 1).  In 
contrast, there were no significant associations between salivary adiponectin and serum 
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inflammatory cytokines (Table 2).  Serum adiponectin was not significantly associated 
with any inflammatory cytokine determination in serum or saliva (Table 2).  
 
 
 
Salivary Adiponectin, Blood Contamination, and Total Protein 
 r= .76, p<.01 
Figure 1.  Correlation between Salivary Adiponectin and Oral Inflammatory 
Activity in Healthy Young Adults (N=96) 
Figure Caption: Salivary adiponectin was significantly positively associated with oral 
inflammatory activity.  
 
Note: Oral Inflammation Composite Score is a composite of salivary IL-1β, IL-6, IL-8 and 
TNFα determinations.  
Winsorized and log-transformed data were used in all analyses.  
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Salivary adiponectin was positively correlated with salivary transferrin and with 
salivary total protein (Table 2). 
Adiponectin with Age, Sex and Body Mass Index 
Neither serum nor salivary adiponectin was associated with participant age or 
BMI.  Females had significantly higher levels of serum adiponectin (M= 12.71 µg/ml, 
SD= 5.013 µg/ml) than males (M= 9.76 µg/ml, SD= 4.79 µg/ml), t(93)= 3.21, p< .01). 
However, there were no sex differences in salivary adiponectin.   
Serum-saliva Correlation for Adiponectin 
 Figure 2 illustrates the bivariate and partial serum-saliva correlations for 
adiponectin.  Serum and salivary adiponectin were positively correlated (r= .39, p<.01; 
d= .85).  To adjust for variations in blood contamination and salivary flow rate, serum-
saliva correlations were performed controlling for salivary transferrin and total protein.  
When controlling for transferrin, there was a significant positive partial correlation 
between salivary and serum adiponectin (n= 92; r= .43, p< .01; d= .95). Similarly, when 
controlling for salivary total protein, the serum saliva correlation for adiponectin was 
positive and significant (n= 95; r= .47, p< .01; d= 1.06).  Further, given the significant 
associations between salivary adiponectin and markers of oral inflammatory activity, 
partial correlations were conducted for serum and salivary adiponectin controlling for 
inflammatory cytokines in saliva. Controlling for the composite oral inflammatory 
activity score, the strength of the serum-saliva correlation for adiponectin increased (n=  
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Bivariate Correlation 
 (n=96, r= .39, p<.01) 
Controlling for salivary transferrin 
(n=90, r=.43, p<.01) 
Controlling for salivary total protein 
(n=93, r=.47, p<.01) 
Controlling for oral inflammatory activity 
 (n=93, r=.53, p<.01) 
Controlling for salivary MMP-8 
 (n=84, r=.50, p<.01) 
Figure 2. Serum-saliva Correlations for Adiponectin in Healthy Young Adults. 
Figure Caption: Serum-saliva correlations for adiponectin were stronger when controlling for potential confounders.  
Note: Oral inflammatory activity is a composite of salivary IL-1β, IL-6, IL-8 and TNFα determinations. Winsorized and log-
transformed data were used in all analyses. MMP-8= matrix metalloproteinase-8. 
19 
 
95; r= .53, p< .01; d= 1.25).  Similarly, the strength of the serum-saliva adiponectin 
partial correlation increased when controlling for salivary MMP-8 (n= 80; r=.50, p<.01; 
d= 1.15).   
Discussion 
This study both confirms previous findings related to adiponectin and provides 
new insight into the characteristics and correlates of adiponectin measured in serum and 
saliva in healthy young adults.  In particular, the study findings provide novel 
information about the utility of salivary adiponectin as a marker for serum adiponectin 
activity.   
Serum and Saliva Adiponectin and Associations with Age, Sex and Body Mass Index 
Our findings are consistent with prior literature showing that adiponectin levels 
are considerably lower in saliva compared to serum (Lin, Maeda, Fukuhara, Shimomura, 
& Ito, 2014).  Also consistent with previous studies, we found that serum adiponectin 
levels were higher in females compared to males (Robinson et al., 2011), while salivary 
adiponectin did not vary by sex (Thanakun et al., 2013).  There were also no differences 
in adiponectin (in serum nor saliva) related to age.   
In our sample of healthy young adults, the majority of whom were of a healthy 
weight, we did not find any associations between adiponectin (in serum or saliva) and 
BMI.  While serum adiponectin has consistently been associated with BMI and obesity 
(Lihn et al., 2005), the link between salivary adiponectin and BMI is not as well 
supported (Mamali et al., 2012; Nigro et al., 2015). The overall health and narrow range 
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of BMI in our sample may have made it more difficult to see an adiponectin-BMI 
association. The relation between BMI and adiponectin may be most pronounced in 
overweight or at-risk populations where metabolic-related diseases are more likely.  
Adiponectin and Inflammatory Activity and Oral Health 
The findings confirmed our hypothesis that salivary adiponectin is strongly 
associated with measures of oral inflammatory activity and oral health.  We found strong 
positive associations between salivary adiponectin and indices of oral inflammatory 
activity and oral health (IL-1β, IL-6, IL-8, TNFα and MMP-8).  While consistent with 
findings from a previous study of healthy adolescent girls (Riis et al., 2013), these 
findings are contrary to findings from in vitro studies of adiponectin’s effect on oral 
epithelial cells, primary gingival fibroblasts, and periodontal ligament cells (Iwayama et 
al., 2012; Kraus et al., 2012). Together, the findings demonstrate the importance of 
assessing adiponectin’s relations with inflammation and health using various approaches 
and populations; the function and proprieties of adiponectin may vary based on 
characteristics of the hormone, its receptors and the health of the individual  
(Almabouada et al., 2013; Li & Wu, 2012). 
Despite strong adiponectin-immune relations in the oral cavity, salivary 
adiponectin was unrelated to self-reported oral hygiene practices. This suggests that these 
self-reported oral health indices are insufficient measures of the oral immune 
environment. The oral hygiene practices questions used in the current study are 
commonly used by salivary bioscience researchers to assess oral health in their analyses. 
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Our results, however, suggest that these indices do not adequately capture the impact of 
the oral immune environment on salivary adiponectin.  To better control for the oral 
health and the oral immune environment, researchers should assess salivary immunologic 
markers.   
We found no evidence of the systemic anti-inflammatory effects of adiponectin in 
our sample. While the anti-inflammatory effects of adiponectin are well-documented 
(Fasshauer & Bluher, 2015; Lihn et al., 2005; Robinson et al., 2011), the influence of 
adiponectin on the surrounding cells likely depends on the health of the individual, and 
on the availably of different isoforms and receptor types (Almabouada et al., 2013; Li & 
Wu, 2012; D. Liu, Luo, & Li, 2015). While it remains unclear why we found no 
significant relations between adiponectin and serum cytokines, it is possible that the 
overall health and homogeneity of our sample made it more difficult to see adiponectin-
immune relations that may be more pronounced under conditions of stress, disease or 
acute inflammation.   
Salivary Confounders of Adiponectin Levels 
The validity of salivary analyte measures as indices of systemic analyte activity 
depends on several factors– most notably the level of blood contamination in the saliva 
and salivary flow rate.  Blood in saliva introduces the possibility that salivary analyte 
concentrations represent greater than normal contributions of serum analyte levels. Blood 
leakage into saliva can also be considered an index of oral health. The positive 
association observed between salivary adiponectin and transferrin may reflect 
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adiponectin’s association with the oral immune environment and/or the effects of blood 
contamination which may elevate measured adiponectin levels as increased adiponectin is 
introduced via blood.   
The effect of salivary flow rate on analyte levels depends on several 
characteristics of the analyte, in particular, its molecular weight and solubility, and the 
mechanism by which the analyte enters saliva.  We found that total protein was positively 
associated with adiponectin levels.  These findings suggest that flow rate and blood 
contamination are two important factors that should be adjusted for when studying 
salivary adiponectin. 
Adiponectin Serum-Saliva Relations 
 Similar to prior investigations, we found a significant, but modest, positive 
association between serum and salivary adiponectin levels (Mamali et al., 2012; 
Thanakun et al., 2013).  Our findings further demonstrate that the magnitude of the 
serum-saliva association is slightly strengthened when controlling for measures of flow 
rate and for blood contamination.  In contrast, controlling for oral health and 
inflammatory markers considerably strengthened the association between salivary and 
serum adiponectin. This, along with strong associations between salivary inflammatory 
biomarkers and salivary adiponectin, suggests that salivary adiponectin is strongly 
associated with immune functioning within the oral cavity, and that adjusting for the oral 
immune environment may improve the utility of salivary adiponectin as a marker of 
systemic adiponectin activity.  
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Strengths and Limitations 
Our data were drawn from a large sample of young adults. The findings are 
strengthened by a wealth of analytic data and matched samples which allowed us to 
directly examine serum-saliva relations controlling for a number of possible confounding 
factors.  Despite the large sample size, the homogeneity of the sample limits the 
generalizability of the findings to young individuals with relatively good oral and 
physical health. Additional research is needed to explore the nature of adiponectin levels 
in serum and saliva in populations with acute and chronic oral and systemic diseases, and 
under conditions of stress and acute inflammation. The homogeneity of the sample also 
prohibited us from examining race and ethnicity differences in adiponectin levels. Race 
and ethnicity differences in adiponectin have been found in prior studies (e.g., Hulver, 
Saleh, MacDonald, Pories, & Barakat, 2004; Lopez-Jaramillo et al., 2014; Ohman-
Hanson et al., 2016) and future study of these differences may help elucidate mechanisms 
underlying health disparities in cardiometabolic conditions.    
Adiponectin circulates in three different molecular weight complexes: a trimer 
(low molecular weight), hexamer (medium molecular weight), and a high molecular 
weight oligomer (HMW; Liu & Liu, 2014).  Studies suggest that the primary species of 
adiponectin in oral fluid is even more complex, a super HMW oligomer (Nigro et al., 
2015).  Antibodies in the adiponectin assays may not necessarily recognize each species 
with the same affinity and may differ in avidity effects with the various complexes of 
adiponectin.  Our anecdotal observations suggest that the levels of adiponectin measured 
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in saliva using modifications of assays produced by different manufacturers, although 
highly intercorrelated, yield very different adiponectin levels. This may have restricted 
the magnitude of the observed serum-saliva association. Our assessment of overall 
adiponectin, rather than isolated adiponectin isoforms, may have also complicated our 
examination of the BMI-adiponectin relationship as the different isoforms have been 
found to correlate differently with changes in weight (Engl et al., 2007). 
Moreover, while total adiponectin in the present study was associated with oral 
inflammatory activity, the actual function of adiponectin in the oral environment remains 
a matter of debate and likely depends on the roles of different isoforms and possibly 
different patterns of expression of adiponectin receptors (Almabouada et al., 2013).  For 
example, a positive effect of total adiponectin on skin keratinocyte proliferation has been 
reported in mice where adiponectin was directly associated with cutaneous wound 
healing (Shibata et al., 2012), and this effect was confirmed in human periodontal 
ligament (PDL) cells (Nokhbehsaim et al., 2014). However, a study in human gingival 
keratinocytes (GK) found no effect of total adiponectin alone on cell proliferation and an 
inhibitive effect in combination with P. gingivalis LPS (Kraus et al., 2012).  Likewise, in 
separate studies, neither MMP-1, IL-6 nor IL-8 protein expression was affected by total 
or globular adiponectin in human GK, gingival fibroblasts (GF) or PDL cells (Iwayama et 
al., 2012; Kraus et al., 2012; Park et al., 2011). Yet, combined stimulation of human GK 
with P. gingivalis LPS and adiponectin, or of GFs with IL-1β and adiponectin, resulted in 
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decreased IL-6 and IL-8 protein expression compared to IL-1β /LPS stimulation alone 
(Iwayama et al., 2012; Kraus et al., 2012).   
Conclusion 
Our findings suggest that salivary adiponectin is strongly related to the oral 
immune environment. Future research should further examine salivary adiponectin as a 
marker of oral health risks, such as gingivitis and periodontal disease, in the general 
population.  The utility of systemic adiponectin levels as a marker of disease risk has 
been the focus of many studies. Promising findings suggest that tracking serum 
adiponectin levels may help in the early detection and disease monitoring of several of 
the most prevalent and costly diseases, such as metabolic syndrome and type-2 diabetes, 
and rheumatoid arthritis (Fasshauer & Bluher, 2015; D. Liu et al., 2015). While 
additional research is needed, particularly with at-risk and diseased participants, our 
findings suggest that salivary adiponectin, when assessed along with the oral immune 
environment, may offer a minimally-invasive and less expensive assessment of systemic 
adiponectin levels.  Future research should continue to explore ways to maximize the 
validity and reliability of salivary adiponectin as a measure of systemic adiponectin 
activity.       
26 
 
References 
Akuailou, E.-N., Vijayagopal, P., Imrhan, V., & Prasad, C. (2013). Measurement and 
validation of the nature of salivary adiponectin. Acta Diabetologica, 50(5), 727–730. 
Almabouada, F., Diaz-Ruiz, A., Rabanal-Ruiz, Y., Peinado, J., Vazquez-Martinez, R., & 
Malagon, M. (2013). Adiponectin receptors form homomers and heteromers 
exhibiting distinct ligand binding and intracellular signaling properties. J Biol 
Chem., 288(5), 3112–25. 
Desai, G. S., & Mathews, S. T. (2014). Saliva as a non-invasive diagnostic tool for 
inflammation and insulin-resistance. World Journal of Diabetes, 5(6), 730–8. 
http://doi.org/10.4239/wjd.v5.i6.730 
Ebrahimi-Mamaeghani, M., Mohammadi, S., Arefhosseini, S. R., Fallah, P., & Bazi, Z. 
(2015). Adiponectin as a potential biomarker of vascular disease. Vascular Health 
and Risk Management, 11, 55–70. http://doi.org/10.2147/VHRM.S48753 
Engl, J., Bobbert, T., Ciardi, C., Laimer, M., Tatarczyk, T., Kaser, S., … Ebenbichler, C. 
(2007). Effects of pronouced weight loss on adiponectin oligomer composition and 
metabolic parameters. Obesity, 15(5), 1172–1178. 
Fasshauer, M., & Bluher, M. (2015). Adiponkines in health and disease. Trends in 
Pharmacological Sciences, 36(7), 461–70. 
Granger, D. A. D. A., Kivlighan, K. T., Fortunato, C., Harmon, A. G. A. G., Hibel, L. C. 
L. C., Schwartz, E. B. E. B., & Whembolua, G.-L. (2007). Integration of salivary 
biomarkers into developmental and behaviorally-oriented research: Problems and 
27 
 
solutions for collecting specimens. Physiology & Behavior, 92(4), 583–590. 
http://doi.org/10.1016/j.physbeh.2007.05.004 
Hulver, M., Saleh, O., MacDonald, K., Pories, W., & Barakat, H. (2004). Ethnic 
differences in adiponectin levels. Metabolism, 53(1), 1–3. 
Iwayama, T., Yanagita, M., Mori, K., Sawada, K., Ozasa, M., Kubota, M., … Murakami, 
S. (2012). Adiponectin regulates functions of gingival fibroblasts and periodontal 
ligament cells. J Periodonal Res, 47(5), 563–71. 
Katsiougiannis, S., Kapsogeorgou, E. K., Manoussakis, M. N., & Skopouli, F. N. (2006). 
Salivary gland epithelial cells: A new source of the immunoregulatory hormone 
adiponectin. Arthritis and Rheumatism, 54(7), 2295–2299. 
http://doi.org/10.1002/art.21944 
Kindt, T., Osborne, B., & Goldsby, R. (2006). Kuby Immunology (6th ed.). W. H. 
Freeman & Company. 
Kivlighan, K. T., Granger, D. A., Schwartz, E. B., Nelson, V., Curran, M., & Shirtcliff, 
E. A. (2004). Quantifying blood leakage into the oral mucosa and its effects on the 
measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. 
Hormones and Behavior, 46(1), 39–46. http://doi.org/10.1016/j.yhbeh.2004.01.006 
Kraus, D., Winter, J., Jepsen, S., Jager, A., Meyer, R., & Deschner, J. (2012). Interactions 
of adiponectin and lipopolysaccharide from Porphyromonas gingivalis on human 
oral epithelial cells. PLoS One, 7(2), e30716. 
Li, L., & Wu, L. (2012). Adiponectin and interleukin-6 in inflammation-association 
28 
 
disease. Vitamins and Hormones, 90, 375–95. 
Lihn, A. S., Pedersen, S. B., & Richelsen, B. (2005). Adiponectin: Action, regulation and 
association to insulin sensitivity. Obesity Reviews, 6(1), 13–21. 
http://doi.org/10.1111/j.1467-789X.2005.00159.x 
Lin, H., Maeda, K., Fukuhara, A., Shimomura, I., & Ito, T. (2014). Molecular expression 
of adiponectin in human saliva. Biochem Biophys Res Commun, 445(2), 294–8. 
Liu, D., Luo, S., & Li, Z. (2015). Multifaceted roles of adiponectin in rheumatoid 
arthritis. International Immunopharmacology, 28, 1084–1090. 
Liu, M., & Liu, F. (2014). Regulation of adiponectin multimerization, signaling and 
function. Best Practice and Research: Clinical Endocrinology and Metabolism, 
28(1), 25–31. http://doi.org/10.1016/j.beem.2013.06.0033 
Lopez-Jaramillo, P., Gomez-Arbelaez, D., Lopez-Lopez, J., Lopez-Lopez, C., Martinez-
Ortega, J., Gomez-Rodriguez, A., & Triana-Cubillos, S. (2014). The role of 
leptin/adiponectin ratio in metabolic syndrome and diabetes. Hormone Molecular 
Biology and Clinical Investigation, 18(1), 37–45. http://doi.org/10.1515/hmbci-
2013-0053 
Mamali, I., Roupas, N., Armeni, A., Theodoropoulou, A., Markou, K., & Georgopoulou, 
N. (2012). Measurement of salivary resistin, visfatin and adiponectin levels. 
Peptides2, 33, 120–124. 
Nigro, E., Piombino, P., Scudiero, O., Monaco, M. L., Schettino, P., Chambery, A., & 
Daniele, A. (2015). Evaluation of salivary adiponectin profile in obese patients. 
29 
 
Peptides, 63, 150–155. http://doi.org/10.1016/j.peptides.2014.11.007 
Nigro, E., Scudiero, O., Monaco, M., Palmieri, A., Mazzarella, G., Costagliola, C., … 
Daniele, A. (2014). New insight into adiponectin role in obesity and obesity-related 
disease. Hindawi Publishing Corporation, Biomedical Research International, 2014. 
Nishanian, P., Aziz, N., Chung, J., Detels, R., & Fahey, J. (1998). Oral fluids as an 
alternative to serum for measurement of immune activation. Clinical and Diagnostic 
Laboratory Immunology, 5(4), 507–512. 
Nokhbehsaim, M., Keser, S., Nogueira, A., Cirelli, J., Jepsen, S., Jäger, A., … Deschner, 
J. (2014). Beneficial effects of adiponectin on periodontal ligament cells under 
normal and regenerative conditions. Journal of Diabetes Research, 2014(796565). 
Ohman-Hanson, R., Cree-Green, M., Kelsey, M., Bessesen, D., Sharp, T., Pyle, L., … 
Nadeau, K. (2016). Ethnic and Sex Differences in Adiponectin: From Childhood to 
Adulthood. J Clin Endocrinol Metab, 101(12), 4808–4815. 
Park, H., Bak, E., Kim, J., Lee, Y., Choi, S., Cha, J., & Yoo, Y. (2011). Effect of globular 
adiponectin on interleukin-6 and interleukin-8 expression in periodontal ligament 
and gingival fibroblasts. J Periodonal Implant Sci, 41(3), 149–56. 
Riis, J. L., Out, D., Dorn, L. D., Beal, S. J., Denson, L., Pabst, S., … Granger, D. A. 
(2013). Salivary cytokines in healthy adolescent girls: Intercorrelations, stability, 
and associations with serum cytokines, age, and pubertal stage. Developmental 
Psychobiology, (June). http://doi.org/10.1002/dev.21149 
Robinson, K., Prins, J., & Venkatesh, B. (2011). Clinical review: adiponectin biology and 
30 
 
its role in inflammation and critical illness. Critical Care (London, England), 15(2), 
221. http://doi.org/10.1186/cc10021 
Scherer, P., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. (1995). A novel serum 
protein similar to C1q, produced exclusively in adipocytes. J Biol Chem., 270(45), 
26746–9. 
Shibata, S., Tada, Y., Asano, Y., Hau, C., Kato, T., Saeki, H., … Sato, S. (2012). 
Adiponectin Regulates Cutaneous Wound Healing by Promoting Keratinocyte 
Proliferation and Migration via the ERK Signaling Pathway. J Immunol, 189(6), 
3231–41. 
Sorsa, T., Tjaderhane, L., & Salo, T. (2004). Matrix metalloproteinases (MMPs) in oral 
diseases. Oral Disease, 10, 311–318. 
Stojanović, S., Ilić, M. D., Ilić, S., Petrović, D., & Djukić, S. (2015). The significance of 
adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease. 
Vojnosanitetski Pregled, 72(9), 779–84. http://doi.org/10.2298/VSP140531067S 
Thanakun, S., Watanabe, H., Thaweboon, S., & Izumi, Y. (2013). An effective technique 
for the processing of saliva for the analysis of leptin and adiponectin. Peptides, 47, 
60–65. 
Vaiopoulos, A., Marinou, K., Christodoulides, C., & Koutsilieris, M. (2012). The role of 
adiponectin in human vascular physiology. Int J Cardiol, 155(2), 188–93. 
 
